PR Newswire Financial
prCenter
New Peer-Reviewed Study Advances CIZ1B Blood Test for Early Lung Cancer Detectiontranslating…
Research supports potential use of CIZ1B to help physicians assess indeterminate pulmonary nodules and guide diagnostic follow-up SAN ANTONIO, Sept. 1, 2026 /PRNewswire/ -- Cizzle Bio Inc., a biotechnology company advancing biomarker blood tests for early cancer detection, has…
Keywords#Cancer Detection#Blood#CIZ1B#Advances#Advances CIZ1B